Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Non-Current Deffered Revenue: 2022-2025

Historic Non-Current Deffered Revenue for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $5.0 million.

  • Immunocore Holdings' Non-Current Deffered Revenue fell 13.83% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 13.83%. This contributed to the annual value of $5.4 million for FY2024, which is 1.47% down from last year.
  • Immunocore Holdings' Non-Current Deffered Revenue amounted to $5.0 million in Q3 2025, which was down 4.80% from $5.2 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Non-Current Deffered Revenue high stood at $5.8 million for Q3 2024, and its period low was $5.0 million during Q3 2025.
  • For the 3-year period, Immunocore Holdings' Non-Current Deffered Revenue averaged around $5.4 million, with its median value being $5.5 million (2024).
  • Per our database at Business Quant, Immunocore Holdings' Non-Current Deffered Revenue grew by 5.21% in 2023 and then decreased by 13.83% in 2025.
  • Immunocore Holdings' Non-Current Deffered Revenue (Quarterly) stood at $5.2 million in 2022, then increased by 5.21% to $5.5 million in 2023, then dropped by 1.47% to $5.4 million in 2024, then decreased by 13.83% to $5.0 million in 2025.
  • Its Non-Current Deffered Revenue was $5.0 million in Q3 2025, compared to $5.2 million in Q2 2025 and $5.6 million in Q1 2025.